drugset / Trial / NCT00020267
Vaccine Therapy in Treating Patients With Metastatic Cancer
Treatment
Summary
RATIONALE: Vaccines made from a peptide may make the body build an immune response and kill tumor cells. PURPOSE: Randomized phase I trial to study the effectiveness of vaccine therapy in treating patients who have metastatic cancer that has not responded to previous therapy.
Timeline
- Start
- 2000-07
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MAGE-12 peptide vaccine | Unknown | — | Subcutaneous |
| Background | aldesleukin | Protein / enzyme biologic | — | Intravenous |
| Background | incomplete Freund's adjuvant | Other / unclassified | — | Subcutaneous |